a slight trendgold
In a phase III study, infusion with autologous tumor cell–bacillus Calmette-Guérin (BCG) vaccine after surgical resection in stage II and III colon cancer patients didn’t show statistically significant differences in clinical outcomes compared with the arm under surgical resection alone, though there was a slight trend in PFS and OS ( 72 ).